TotalMarketCap

Faeth Therapeutics

FTHNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$509.901 M

$19.73 -1.30%

Close of 6 Nov 2026

As of 6 Nov 2026, Faeth Therapeutics (FTH) has a market capitalization of $509.9M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$21.1M

Loss-making

Shares outstanding

25,843,945

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #184NeurogeneNGNE$516.1M
  2. #185Climb BioCLYM$510.0M
  3. #186Faeth TherapeuticsFTH$509.9M
  4. #187Puma BiotechnologyPBYI$505.4M
  5. #188Ovid TherapeuticsOVID$503.9M

What if Faeth Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,092,591

Per share 55,377× higher

Bitcoin $1.53T

$59,118.22

Per share 2,996× higher

Apple $5.02T

$194,079.60

Per share 9,837× higher

Or at a round number

$1.00B$2.00B$5.00B$10.0B

Where these numbers come from

Share counts and financials for Faeth Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.